Cheaper isn't always necessarily better. If you can buy something worth owning at a nice discount, though, you should. Here's a rundown of three dividend stocks that not only boast nice dividend yields, but are priced dirt cheap. These low valuations suggest there's little downside left to price in -- only upside potential. If it seems like drugmaker Bristol Myers Squibb (NYSE: BMY) was suspiciously left out of conversations about COVID-19 vaccines -- and more recently, weight loss drugs -- you're not imagining things. The company has kept its focus on blood-thinning Eliquis and cancer-treatment Opdivo, leaving it off of most investors' radars of late. That's a big reason the stock's made no net progress since 2020. Don't mistake boring predictability for underperformance, though. This may not be a high-growth pharma company, but it's an income powerhouse, having paid dividends every year for the past 94 years and raising its annual payout for the past 17 of them. You're not only plugging into a forward-looking yield of 4.2%, but buying into a stock that's priced at less than 10 times this year's expected per-share profit.
CryptoAlerta — análise de criptomoedas e mercado em tempo real